甘油三酯葡萄糖乘积指数与胰岛素抵抗在肾脏疾病中的研究进展
Research Progress of Triglyceride Glucose Product Index and Insulin Resistance in Re-nal Disease
摘要: 近年来,甘油三酯葡萄糖乘积指数(TyG指数)已经成为研究热点,是评估胰岛素抵抗(IR)的新型指标。有研究发现该指数是评估蛋白尿、慢性肾脏病(CKD)及心血管疾病(CVD)等的有效生物标志物。同时,目前已被证明与2型糖尿病、代谢综合征、血管性认知功能障碍、多囊卵巢综合征、恶性肿瘤等多种疾病风险相关。本文主要针对TyG指数在肾脏疾病中的研究进展做一综述,以期为肾脏疾病进展、并发症防治和预后的预测提供新依据,为临床早期诊断和干预提供新思路。
Abstract: In recent years, the Triglyceride-Glucose Index (TyG index) has become a research hotspot and is a new index for evaluating insulin resistance (IR). Studies have found that the index is an effective biomarker for evaluating proteinuria, chronic kidney disease (CKD) and cardiovascular disease (CVD). At the same time, it has been proven to be associated with the risk of various diseases, such as type 2 diabetes, metabolic syndrome, vascular cognitive impairment, polycystic ovary syndrome and malignant tumors. This article mainly reviews the research progress of TyG index in renal disease, in order to provide a new basis for the prediction of renal disease progression, complication prevention and prognosis, and to provide new ideas for early clinical diagnosis and intervention.
文章引用:李雯静, 杨小娟. 甘油三酯葡萄糖乘积指数与胰岛素抵抗在肾脏疾病中的研究进展[J]. 临床医学进展, 2022, 12(4): 3550-3558. https://doi.org/10.12677/ACM.2022.124515

参考文献

[1] Schrauben, S.J., Jepson, C., Hsu, J.Y., et al. (2019) Insulin Resistance and Chronic Kidney Disease Progression, Car-diovascular Events, and Death: Findings from the Chronic Renal Insufficiency Cohort Study. BMC Nephrology, 20, Article No. 60. [Google Scholar] [CrossRef] [PubMed]
[2] Gansevoort, R.T., Correa-Rotter, R., Hemmelgarn, B.R., et al. (2013) Chronic Kidney Disease and Cardiovascular Risk: Epidemiology, Mechanisms, and Prevention. The Lancet, 382, 339-352. [Google Scholar] [CrossRef
[3] 王青. 终末期肾病患者死因与心血管疾病相关性的探讨[J]. 中国热带医学, 2007, 7(8): 1398-1399.
[4] Patel, T.P., Rawal, K., Bagchi, A.K., et al. (2016) Insulin Resistance: An Additional Risk Factor in the Pathogenesis of Cardiovascular Disease in Type 2 Diabetes. Heart Failure Reviews, 21, 11-23. [Google Scholar] [CrossRef] [PubMed]
[5] Chan, D.T., Watts, G.F., Irish, A.B., et al. (2017) Insulin Re-sistance and Vascular Dysfunction in Chronic Kidney Disease: Mechanisms and Therapeutic Interventions. Nephrology Dialysis Transplantation, 32, 1274-1281.
[6] Okamura, T., Hashimoto, Y., Hamaguchi, M., et al. (2019) Triglyc-eride-Glucose Index Is a Predictor of Incident Chronic Kidney Disease: A Population-Based Longitudinal Study. Clinical and Experimental Nephrology, 23, 948-955. [Google Scholar] [CrossRef] [PubMed]
[7] Sánchez-García, A., Rodríguez-Gutiérrez, R., Mancillas-Adame, L., et al. (2020) Diagnostic Accuracy of the Triglyceride and Glucose Index for Insulin Resistance: A Systematic Review. International Journal of Endocrinology, 2020, Article ID: 4678526. [Google Scholar] [CrossRef] [PubMed]
[8] Okamura, T., Hashimoto, Y., Hamaguchi, M., et al. (2020) Triglyc-eride-Glucose Index (TyG Index) Is a Predictor of Incident Colorectal Cancer: A Population-Based Longitudinal Study. BMC Endocrine Disorders, 20, Article No. 113. [Google Scholar] [CrossRef] [PubMed]
[9] Shi, Y., Hu, L., Li, M., et al. (2022) Association between the Surrogate Markers of Insulin Resistance and Chronic Kidney Disease in Chinese Hypertensive Patients. Frontiers in Medicine (Lausanne), 9, Article ID: 831648. [Google Scholar] [CrossRef] [PubMed]
[10] Ding, X., Wang, X., Wu, J., et al. (2021) Triglyceride-Glucose Index and the Incidence of Atherosclerotic Cardiovascular Diseases: A Meta-Analysis of Cohort Studies. Cardiovascular Diabetology, 20, 76. [Google Scholar] [CrossRef] [PubMed]
[11] Gao, W., Wang, J., Chen, Y., et al. (2021) Discordance between the Triglyceride Glucose Index and HOMA-IR in Incident Albuminuria: A Cohort Study from China. Lipids in Health and Disease, 20, 176. [Google Scholar] [CrossRef] [PubMed]
[12] Simental-Mendía, L.E., Rodríguez-Morán, M. and Guerre-ro-Romero, F. (2008) The Product of Fasting Glucose and Triglycerides as Surrogate for Identifying Insulin Resistance in Apparently Healthy Subjects. Metabolic Syndrome and Related Disorders, 6, 299-304. [Google Scholar] [CrossRef] [PubMed]
[13] DeFronzo, R.A., Tobin, J.D. and Andres, R. (1979) Glucose Clamp Technique: A Method for Quantifying Insulin Secretion and Resistance. American Journal of Physiology, 237, E214-E223. [Google Scholar] [CrossRef
[14] 李光伟. 胰岛素抵抗评估及其临床应用[J]. 中华老年多器官疾病杂志, 2004, 3(1): 11-12.
[15] Lim, J., Kim, J., Koo, S.H., et al. (2019) Comparison of Triglyceride Glucose Index, and Related Parameters to Predict Insulin Resistance in Korean Adults: An Analysis of the 2007-2010 Korean National Health and Nutrition Examination Survey. PLoS ONE, 14, e212963. [Google Scholar] [CrossRef] [PubMed]
[16] Er, L.K., Wu, S., Chou, H.H., et al. (2016) Triglyceride Glu-cose-Body Mass Index Is a Simple and Clinically Useful Surrogate Marker for Insulin Resistance in Nondiabetic Indi-viduals. PLoS ONE, 11, e149731. [Google Scholar] [CrossRef] [PubMed]
[17] 张琴. TyG指数对胰岛素抵抗及胰岛β细胞功能的双重评估[D]: [硕士学位论文]. 重庆: 重庆医科大学, 2014.
[18] Wang, Z., Zhao, L. and He, S. (2021) Triglyceride-Glucose Index as Predictor for Future Type 2 Diabetes Mellitus in a Chinese Population in Southwest China: A 15-Year Prospective Study. Endocrine, 72, 124-131. [Google Scholar] [CrossRef] [PubMed]
[19] Lee, J.H., Park, S.K., Ryoo, J.H., et al. (2017) The Association between Insulin Resistance and Depression in the Korean General Population. Journal of Affective Disorders, 208, 553-559. [Google Scholar] [CrossRef] [PubMed]
[20] de Cuevillas, B., Alvarez-Alvarez, I., Riezu-Boj, J.I., et al. (2021) The Hypertriglyceridemia-Waist Phenotype as a Valuable and Integrative Mirror of Metabolic Syndrome Traits. Scientific Reports, 11, Article No. 21859. [Google Scholar] [CrossRef] [PubMed]
[21] Huanan, C., Sangsang, L., Amoah, A.N., et al. (2020) Rela-tionship between Triglyceride Glucose Index and the Incidence of Non-Alcoholic Fatty Liver Disease in the Elderly: A Retrospective Cohort Study in China. BMJ Open, 10, e39804. [Google Scholar] [CrossRef] [PubMed]
[22] Kheirollahi, A., Teimouri, M., Karimi, M., et al. (2020) Evaluation of Lipid Ratios and Triglyceride-Glucose Index as Risk Markers of Insulin Resistance in Iranian Polycystic Ovary Syndrome Women. Lipids in Health and Disease, 19, 235. [Google Scholar] [CrossRef] [PubMed]
[23] Jiang, T., Zhou, Y., Zhang, D., et al. (2021) Association of Se-rum Interleukin-34 and Insulin Resistance with Cognitive Impairment in Patients with Cerebral Small Vessel Disease. Current Neurovascular Research, 18, 446-455. [Google Scholar] [CrossRef] [PubMed]
[24] Panigoro, S.S., Sutandyo, N., Witjaksono, F., et al. (2021) The Association Between Triglyceride-Glucose Index as a Marker of Insulin Resistance and the Risk of Breast Cancer. Frontiers in Endocrinology (Lausanne), 12, Article ID: 745236. [Google Scholar] [CrossRef] [PubMed]
[25] Kobayashi, S., Maesato, K., Moriya, H., et al. (2005) Insulin Re-sistance in Patients with Chronic Kidney Disease. American Journal of Kidney Diseases, 45, 275-280. [Google Scholar] [CrossRef] [PubMed]
[26] Spoto, B., Pisano, A. and Zoccali, C. (2016) Insulin Resistance in Chronic Kidney Disease: A Systematic Review. American Journal of Physiology-Renal Physiology, 311, F1087-F1108. [Google Scholar] [CrossRef] [PubMed]
[27] Hosoya, K., Minakuchi, H., Wakino, S., et al. (2015) Insulin Resistance in Chronic Kidney Disease Is Ameliorated by Spironolactone in Rats and Humans. Kidney International, 87, 749-760. [Google Scholar] [CrossRef] [PubMed]
[28] Dave, N., Wu, J. and Thomas, S. (2018) Chronic Kidney Dis-ease-Induced Insulin Resistance: Current State of the Field. Current Diabetes Reports, 18, 44. [Google Scholar] [CrossRef] [PubMed]
[29] Abdalla, M. (2021) Salivary Resistin Level and Its Association with Insulin Resistance in Obese Individuals. World Journal of Diabetes, 12, 1507-1517. [Google Scholar] [CrossRef] [PubMed]
[30] 夏灵伟. 腹膜透析患者脂联素、抵抗素和脂代谢状态及胰岛素抵抗的相关性研究[D]: [硕士学位论文]. 天津: 天津医科大学, 2016.
[31] Zhao, A.Z., Bornfeldt, K.E. and Beavo, J.A. (1998) Leptin Inhibits Insulin Secretion by Activation of Phosphodiesterase 3B. The Journal of Clinical Investigation, 102, 869-873. [Google Scholar] [CrossRef
[32] Valkenburg, S., Glorieux, G. and Vanholder, R. (2021) Uremic Toxins and Cardiovascular System. Cardiology Clinics, 39, 307-318. [Google Scholar] [CrossRef] [PubMed]
[33] Helal, I., Fick-Brosnahan, G.M., Reed-Gitomer, B., et al. (2012) Glomerular Hyperfiltration: Definitions, Mechanisms and Clinical Implications. Nature Reviews Nephrology, 8, 293-300. [Google Scholar] [CrossRef] [PubMed]
[34] Carrero, J.J., Grams, M.E., Sang, Y., et al. (2017) Albuminuria Changes Are Associated with Subsequent Risk of End-Stage Renal Disease and Mortality. Kidney International, 91, 244-251. [Google Scholar] [CrossRef] [PubMed]
[35] Liu, D. and Lv, L.L. (2019) New Understanding on the Role of Proteinuria in Progression of Chronic Kidney Disease. Advances in Experimental Medicine and Biology, 1165, 487-500. [Google Scholar] [CrossRef] [PubMed]
[36] Zhao, S., Yu, S., Chi, C., et al. (2019) Association between Macro- and Microvascular Damage and the Triglyceride Glucose Index in Community-Dwelling Elderly Individuals: The Northern Shanghai Study. Cardiovascular Diabetology, 18, 95. [Google Scholar] [CrossRef] [PubMed]
[37] Ou, Y.L., Lee, M.Y., Lin, I.T., et al. (2021) Obesity-Related In-dices Are Associated with Albuminuria and Advanced Kidney Disease in Type 2 Diabetes Mellitus. Renal Failure, 43, 1250-1258. [Google Scholar] [CrossRef
[38] Pan, Y., Zhong, S., Zhou, K., et al. (2021) Association between Diabetes Complications and the Triglyceride-Glucose Index in Hospitalized Patients with Type 2 Diabetes. Journal of Diabetes Research, 2021, Article ID: 8757996. [Google Scholar] [CrossRef] [PubMed]
[39] Chiu, H., Tsai, H.J., Huang, J.C., et al. (2020) Associations between Triglyceride-Glucose Index and Micro- and Macro-Angiopathies in Type 2 Diabetes Mellitus. Nutrients, 12, 328. [Google Scholar] [CrossRef] [PubMed]
[40] Ammirati, A.L. (2020) Chronic Kidney Disease. Revista da Associacao Medica Brasileira (1992), 66, s3-s9. [Google Scholar] [CrossRef] [PubMed]
[41] Zhang, L., Wang, F., Wang, L., et al. (2012) Prevalence of Chronic Kidney Disease in China: A Cross-Sectional Survey. The Lancet, 379, 815-822. [Google Scholar] [CrossRef
[42] Xu, X., Tang, X., Che, H., et al. (2021) Triglyceride-Glucose Product Is an Independent Risk Factor for Predicting Chronic Kidney Disease in Middle-Aged and Elderly Population: A Prospective Cohort Study. Journal of Southern Medical University, 41, 1600-1608.
[43] Fritz, J., Brozek, W., Concin, H., et al. (2021) The Triglyceride-Glucose Index and Obesity-Related Risk of End-Stage Kidney Disease in Austrian Adults. JAMA Network Open, 4, e212612. [Google Scholar] [CrossRef] [PubMed]
[44] Lambie, M., Bonomini, M., Davies, S.J., et al. (2021) Insulin Resistance in Cardiovascular Disease, Uremia, and Peritoneal Dialysis. Trends in Endocrinology & Metabolism, 32, 721-730. [Google Scholar] [CrossRef] [PubMed]
[45] Artunc, F., Schleicher, E., Weigert, C., et al. (2016) The Impact of Insulin Resistance on the Kidney and Vasculature. Nature Reviews Nephrology, 12, 721-737. [Google Scholar] [CrossRef] [PubMed]
[46] Park, K., Ahn, C.W., Lee, S.B., et al. (2019) Elevated TyG Index Predicts Progression of Coronary Artery Calcification. Diabetes Care, 42, 1569-1573. [Google Scholar] [CrossRef] [PubMed]
[47] Alizargar, J., Bai, C.H., Hsieh, N.C., et al. (2020) Use of the Triglycer-ide-Glucose Index (TyG) in Cardiovascular Disease Patients. Cardiovascular Diabetology, 19, 8. [Google Scholar] [CrossRef] [PubMed]
[48] Da, S.A., Caldas, A., Hermsdorff, H., et al. (2019) Triglycer-ide-Glucose Index Is Associated with Symptomatic Coronary Artery Disease in Patients in Secondary Care. Cardio-vascular Diabetology, 18, 89. [Google Scholar] [CrossRef] [PubMed]
[49] Chiu, T.H., Tsai, H.J., Chiou, H.C., et al. (2021) A High Tri-glyceride-Glucose Index Is Associated with Left Ventricular Dysfunction and Atherosclerosis. International Journal of Medical Sciences, 18, 1051-1057. [Google Scholar] [CrossRef] [PubMed]
[50] Wu, S., Xu, L., Wu, M., et al. (2021) Association between Triglycer-ide-Glucose Index and Risk of Arterial Stiffness: A Cohort Study. Cardiovascular Diabetology, 20, 146. [Google Scholar] [CrossRef] [PubMed]
[51] Lee, S.B., Ahn, C.W., Lee, B.K., et al. (2018) Association be-tween Triglyceride Glucose Index and Arterial Stiffness in Korean Adults. Cardiovascular Diabetology, 17, 41. [Google Scholar] [CrossRef] [PubMed]
[52] Glassock, R.J., Warnock, D.G. and Delanaye, P. (2017) The Global Burden of Chronic Kidney Disease: Estimates, Variability and Pitfalls. Nature Reviews Nephrology, 13, 104-114. [Google Scholar] [CrossRef] [PubMed]
[53] Yan, Z., Yu, D., Cai, Y., et al. (2019) Triglyceride Glucose Index Predicting Cardiovascular Mortality in Chinese Initiating Peritoneal Dialysis: A Cohort Study. Kidney and Blood Pressure Research, 44, 669-678. [Google Scholar] [CrossRef] [PubMed]
[54] Torres, M.L., Caldas, S.A., Da, S.E.S.F., et al. (2021) Use of Neck Cir-cumference as a Predictor of Cardiovascular Risk in Chronic Kidney Patients Undergoing Haemodialysis Who Are Candidates for Transplantation. Journal of Human Nutrition and Dietetics, 34, 758-767. [Google Scholar] [CrossRef] [PubMed]
[55] 张素兰, 陈铖, 苏可. 糖尿病肾病生物标志物的研究进展[J]. 中华实用诊断与治疗杂志, 2022, 36(3): 314-316.
[56] Liu, L., Xia, R., Song, X., et al. (2021) Association between the Tri-glyceride-Glucose Index and Diabetic Nephropathy in Patients with Type 2 Diabetes: A Cross-Sectional Study. Journal of Diabetes Investigation, 12, 557-565. [Google Scholar] [CrossRef] [PubMed]
[57] Srinivasan, S., Singh, P., Kulothungan, V., et al. (2021) Relationship be-tween Triglyceride Glucose Index, Retinopathy and Nephropathy in Type 2 Diabetes. Endocrinology, Diabetes & Me-tabolism, 4, e151. [Google Scholar] [CrossRef] [PubMed]
[58] Lv, L., Zhou, Y., Chen, X., et al. (2021) Relationship between the TyG Index and Diabetic Kidney Disease in Patients with Type-2 Diabetes Mellitus. Diabetes, Metabolic Syndrome and Obesity, 14, 3299-3306. [Google Scholar] [CrossRef
[59] Shang, J., Yu, D., Cai, Y., et al. (2019) The Triglyceride Glucose Index Can Predict Newly Diagnosed Biopsy-Proven Diabetic Nephropathy in Type 2 Diabetes: A Nested Case Control Study. Medicine (Baltimore), 98, e17995. [Google Scholar] [CrossRef
[60] Spatola, L., Ferraro, P.M., Gambaro, G., et al. (2018) Met-abolic Syndrome and Uric Acid Nephrolithiasis: Insulin Resistance in Focus. Metabolism, 83, 225-233. [Google Scholar] [CrossRef] [PubMed]
[61] Jiang, H., Li, L., Liu, J., et al. (2021) Triglyceride-Glucose Index as a Novel Biomarker in the Occurrence of Kidney Stones: A Cross-Sectional Population-Based Study. Interna-tional Journal of General Medicine, 14, 6233-6244. [Google Scholar] [CrossRef
[62] Qin, Z., Zhao, J., Geng, J., et al. (2021) Higher Triglyceride-Glucose Index Is Associated With Increased Likelihood of Kidney Stones. Frontiers in Endocrinology (Lausanne), 12, Article ID: 774567. [Google Scholar] [CrossRef] [PubMed]
[63] Stacul, F., van der Molen, A.J., Reimer, P., et al. (2011) Contrast Induced Nephropathy: Updated ESUR Contrast Media Safety Committee Guidelines. European Radiology, 21, 2527-2541. [Google Scholar] [CrossRef] [PubMed]
[64] Li, M., Li, L., Qin, Y., et al. (2022) Elevated TyG Index Predicts Incidence of Contrast-Induced Nephropathy: A Retrospective Cohort Study in NSTE-ACS Patients Im-planted with DESs. Frontiers in Endocrinology (Lausanne), 13, Article ID: 817176. [Google Scholar] [CrossRef] [PubMed]
[65] Qin, Y., Tang, H., Yan, G., et al. (2020) A High Triglycer-ide-Glucose Index Is Associated with Contrast-Induced Acute Kidney Injury in Chinese Patients with Type 2 Diabetes Mellitus. Frontiers in Endocrinology (Lausanne), 11, Article ID: 522883. [Google Scholar] [CrossRef] [PubMed]